Tumour model

B-LCL-CDG1

Congenital Disorders of Glycosylation
XenograftIn vitro

Model characteristics

Organism
Human
Tissue of origin
Peripheral blood
Pathology
Congenital Disorders of Glycosylation
Model type
In vitro, Xenograft
Availability
2 to 3 weeks

Request this model

Tell us about your compound and your endpoints. Our team confirms feasibility, timelines and study design before any commitment.

Related models

Other models sharing the same tissue of origin.

Model
Organism
Tissue of origin
Pathology
Type

HEL

Human
Peripheral blood
Erythroleukemia
XenograftIn vitro
Mouse
Peripheral blood
Leukemia
SyngeneicIn vitro

COX

Human
Peripheral blood
Burkitt lymphoma
XenograftIn vitro
Human
Peripheral blood
Normal
XenograftIn vitro
Human
Peripheral blood
Congenital Disorders of Glycosylation
XenograftIn vitro
Human
Peripheral blood
Burkitt's lymphoma
XenograftIn vitroResistant